` 300003 (Lepu Medical Technology Beijing Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

L
300003
vs
S
Shanghai Composite

Over the past 12 months, Lepu Medical Technology Beijing Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +50% compared to the Shanghai Composite's +27% growth.

Stocks Performance
300003 vs Shanghai Composite

Loading
300003
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
300003 vs Shanghai Composite

Loading
300003
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
300003 vs Shanghai Composite

Loading
300003
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Lepu Medical Technology Beijing Co Ltd vs Peers

Shanghai Composite
300003
LEG
PMT
DFS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Lepu Medical Technology Beijing Co Ltd
Glance View

Market Cap
30.1B CNY
Industry
Health Care

Lepu Medical Technology Beijing Co Ltd. was born in the vibrant landscape of China's rapidly evolving healthcare industry. Established in 1999, the company has grown into a formidable player in the medical device sector. It carved its niche by focusing on cardiovascular interventions, technological innovations, and pharmaceuticals. At its core, Lepu Medical thrives on leveraging its research and development expertise to create products that cater to a broad spectrum of medical needs, particularly in the cardiovascular domain. They manufacture and distribute a wide range of medical devices which include coronary stents, pacemakers, and other related products, enabling them to secure a strong foothold in both domestic and international markets. Revenue generation for Lepu Medical is a multifaceted process that leverages the company's comprehensive vertical integration strategy. The company has strategically developed a robust portfolio not only in medical devices but also in pharmaceuticals and healthcare services. This diversified offering allows them to capture value across the entire patient care continuum—from device manufacturing and pharmaceuticals to post-operative care and services. By continually investing in innovation and expanding their reach through strategic partnerships and acquisitions, Lepu Medical ensures a consistent revenue stream, reinforcing its position within the global healthcare landscape. The company's commitment to quality and technological advancement keeps it competitive, propelling its growth across various health sectors.

Intrinsic Value
15.51 CNY
Overvaluation 5%
Intrinsic Value
Price ¥16.31
L
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett